Base-Edited Hematopoietic Stem/Progenitor Cell X-Linked Severe Combined Immunodeficiency Gene Therapy
Clinical trial NCT06851767 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT06851767
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-09
- Primary completion
- 2034-12-31
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.